Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

More articles from Minireview

  • Mutation-associated fusion cancer genes in solid tumors
    Frederic J. Kaye
    Molecular Cancer Therapeutics Jun 2009, 8 (6) 1399-1408; DOI: 10.1158/1535-7163.MCT-09-0135
  • Epigenetics in cancer: Targeting chromatin modifications
    Leigh Ellis, Peter W. Atadja, Ricky W. Johnstone
    Molecular Cancer Therapeutics Jun 2009, 8 (6) 1409-1420; DOI: 10.1158/1535-7163.MCT-08-0860
  • Regulated cell death pathways: New twists in modulation of BCL2 family function
    Nidhish Sasi, Misun Hwang, Jerry Jaboin, Ildiko Csiki, Bo Lu
    Molecular Cancer Therapeutics Jun 2009, 8 (6) 1421-1429; DOI: 10.1158/1535-7163.MCT-08-0895
  • Niacin status and treatment-related leukemogenesis
    James B. Kirkland
    Molecular Cancer Therapeutics Apr 2009, 8 (4) 725-732; DOI: 10.1158/1535-7163.MCT-09-0042
  • Discovery of Ixabepilone
    John T. Hunt
    Molecular Cancer Therapeutics Feb 2009, 8 (2) 275-281; DOI: 10.1158/1535-7163.MCT-08-0999
  • Genes to vaccines for immunotherapy: how the molecular biology revolution has influenced cancer immunology
    Dan A. Laheru, Drew M. Pardoll, Elizabeth M. Jaffee
    Molecular Cancer Therapeutics Nov 2005, 4 (11) 1645-1652; DOI: 10.1158/1535-7163.MCT-05-0151
  • PRL phosphatases as potential molecular targets in cancer
    Bret J. Stephens, Haiyong Han, Vijay Gokhale, Daniel D. Von Hoff
    Molecular Cancer Therapeutics Nov 2005, 4 (11) 1653-1661; DOI: 10.1158/1535-7163.MCT-05-0248
  • Using bioinformatics and genome analysis for new therapeutic interventions
    David W. Mount, Ritu Pandey
    Molecular Cancer Therapeutics Oct 2005, 4 (10) 1636-1643; DOI: 10.1158/1535-7163.MCT-05-0150
  • Interaction between epidermal growth factor receptor– and cyclooxygenase 2–mediated pathways and its implications for the chemoprevention of head and neck cancer
    Mi Sun Choe, Xin Zhang, Hyung Ju C. Shin, Dong M. Shin, Zhuo (Georgia) Chen
    Molecular Cancer Therapeutics Sep 2005, 4 (9) 1448-1455; DOI: 10.1158/1535-7163.MCT-04-0251
  • Proteasome inhibitor therapy in multiple myeloma
    Dharminder Chauhan, Teru Hideshima, Constantine Mitsiades, Paul Richardson, Kenneth C. Anderson
    Molecular Cancer Therapeutics Apr 2005, 4 (4) 686-692; DOI: 10.1158/1535-7163.MCT-04-0338

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement